BRUKER CORPORATION Operating Cash Flow
BRUKER CORPORATION (BRKR) reported Operating Cash Flow of -$6.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- BRUKER CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$77.40M.
- BRUKER CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $71.20M, a 9.54% increase year-over-year.
- BRUKER CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $229.80M, a 20.95% increase year-over-year.
- BRUKER CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$33.20M, a 186.46% decline year-over-year.
- BRUKER CORPORATION net cash provided by (used in) operating activities for fiscal 2025 was $134.10M, a 46.64% decline from fiscal 2024.
- BRUKER CORPORATION net cash provided by (used in) operating activities for fiscal 2024 was $251.30M, a 28.22% decline from fiscal 2023.
- BRUKER CORPORATION net cash provided by (used in) operating activities for fiscal 2023 was $350.10M, a 27.59% increase from fiscal 2022.
- BRUKER CORPORATION net cash provided by (used in) operating activities for fiscal 2022 was $274.40M, a 2.83% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$77.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$6.20M 10-Q · filed 2026-08-05 | $223.60M derived: sum of 3 quarters · filed 2026-08-05 | $190.40M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $71.20M 10-Q · filed 2026-05-07 | $301.00M derived: sum of 2 quarters · filed 2026-05-07 | $267.80M derived: sum of 3 quarters · filed 2026-05-07 | $140.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $229.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $196.60M derived: sum of 2 quarters · filed 2026-02-27 | $69.10M derived: sum of 3 quarters · filed 2026-08-05 | $134.10M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$33.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$160.70M derived: sum of 2 quarters · filed 2026-08-05 | -$95.70M 10-Q · filed 2025-11-05 | $94.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$127.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$62.50M 10-Q · filed 2026-08-05 | $127.50M derived: sum of 3 quarters · filed 2026-08-05 | $165.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $65.00M 10-Q · filed 2026-05-07 | $255.00M derived: sum of 2 quarters · filed 2026-05-07 | $293.40M derived: sum of 3 quarters · filed 2026-05-07 | $294.50M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $190.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $228.40M derived: sum of 2 quarters · filed 2026-02-27 | $229.50M derived: sum of 3 quarters · filed 2026-02-27 | $251.30M 10-K · filed 2026-02-27 |
| 2024-09-30 | $38.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $39.50M derived: sum of 2 quarters · filed 2025-11-05 | $61.30M 10-Q · filed 2025-11-05 | $266.80M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $22.90M 10-Q · filed 2025-08-06 | $228.40M derived: sum of 3 quarters · filed 2026-02-27 | $272.50M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $21.80M 10-Q · filed 2025-05-07 | $227.30M derived: sum of 2 quarters · filed 2026-02-27 | $271.40M derived: sum of 3 quarters · filed 2026-02-27 | $284.40M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $205.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $249.60M derived: sum of 2 quarters · filed 2026-02-27 | $262.60M derived: sum of 3 quarters · filed 2026-02-27 | $350.10M 10-K · filed 2026-02-27 |
| 2023-09-30 | $44.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $57.10M derived: sum of 2 quarters · filed 2024-11-07 | $144.60M 10-Q · filed 2024-11-07 | $316.10M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $100.50M 10-Q · filed 2024-08-09 | $272.00M derived: sum of 3 quarters · filed 2025-03-03 | $341.50M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $87.50M 10-Q · filed 2024-05-10 | $259.00M derived: sum of 2 quarters · filed 2025-03-03 | $328.50M derived: sum of 3 quarters · filed 2025-03-03 | $284.10M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $171.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $241.00M derived: sum of 2 quarters · filed 2025-03-03 | $196.60M derived: sum of 3 quarters · filed 2025-03-03 | $274.40M 10-K · filed 2025-03-03 |
| 2022-09-30 | $69.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $25.10M derived: sum of 2 quarters · filed 2023-11-09 | $102.90M 10-Q · filed 2023-11-09 | $241.50M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$44.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $33.40M 10-Q · filed 2023-08-09 | $172.00M derived: sum of 3 quarters · filed 2024-02-29 | $195.90M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $77.80M 10-Q · filed 2023-05-10 | $216.40M derived: sum of 2 quarters · filed 2024-02-29 | $240.30M derived: sum of 3 quarters · filed 2024-02-29 | $262.20M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $138.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $162.50M derived: sum of 2 quarters · filed 2024-02-29 | $184.40M derived: sum of 3 quarters · filed 2024-02-29 | $282.40M 10-K · filed 2024-02-29 |
| 2021-09-30 | $23.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $45.80M derived: sum of 2 quarters · filed 2022-11-04 | $143.80M 10-Q · filed 2022-11-04 | $346.80M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $21.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $119.90M 10-Q · filed 2022-08-05 | $322.90M derived: sum of 3 quarters · filed 2023-03-01 | $405.30M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $98.00M 10-Q · filed 2022-05-06 | $301.00M derived: sum of 2 quarters · filed 2023-03-01 | $383.40M derived: sum of 3 quarters · filed 2023-03-01 | $395.20M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $203.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $285.40M derived: sum of 2 quarters · filed 2023-03-01 | $297.20M derived: sum of 3 quarters · filed 2023-03-01 | $332.20M 10-K · filed 2023-03-01 |
| 2020-09-30 | $82.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $94.20M derived: sum of 2 quarters · filed 2021-11-05 | $129.20M 10-Q · filed 2021-11-05 | $265.40M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $11.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $46.80M 10-Q · filed 2021-08-05 | $183.00M derived: sum of 3 quarters · filed 2022-02-28 | $235.40M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $35.00M 10-Q · filed 2021-05-10 | $171.20M derived: sum of 2 quarters · filed 2022-02-28 | $223.60M derived: sum of 3 quarters · filed 2022-02-28 | $234.20M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $136.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $188.60M derived: sum of 2 quarters · filed 2022-02-28 | $199.20M derived: sum of 3 quarters · filed 2022-02-28 | $213.40M 10-K · filed 2022-02-28 |
| 2019-09-30 | $52.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $63.00M derived: sum of 2 quarters · filed 2020-11-06 | $77.20M 10-Q · filed 2020-11-06 | $209.50M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $10.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $24.80M 10-Q · filed 2020-08-07 | $157.10M derived: sum of 3 quarters · filed 2021-03-01 | $184.60M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $14.20M 10-Q · filed 2020-05-11 | $146.50M derived: sum of 2 quarters · filed 2021-03-01 | $174.00M derived: sum of 3 quarters · filed 2021-03-01 | $210.10M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $132.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $159.80M derived: sum of 2 quarters · filed 2021-03-01 | $195.90M derived: sum of 3 quarters · filed 2021-03-01 | $239.70M 10-K · filed 2021-03-01 |
| 2018-09-30 | $27.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $63.60M derived: sum of 2 quarters · filed 2019-11-04 | $107.40M 10-Q · filed 2019-11-04 | $211.10M derived: sum of 4 quarters · filed 2020-03-27 |
| 2018-06-30 | $36.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $79.90M 10-Q · filed 2019-08-09 | $183.60M derived: sum of 3 quarters · filed 2020-03-27 | $218.90M derived: sum of 4 quarters · filed 2020-03-27 |
| 2018-03-31 | $43.80M 10-Q · filed 2019-05-08 | $147.50M derived: sum of 2 quarters · filed 2020-03-27 | $182.80M derived: sum of 3 quarters · filed 2020-03-27 | $165.60M derived: sum of 4 quarters · filed 2020-03-27 |
| 2017-12-31 | $103.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $139.00M derived: sum of 2 quarters · filed 2020-03-27 | $121.80M derived: sum of 3 quarters · filed 2020-03-27 | $154.40M 10-K · filed 2020-03-27 |
| 2017-09-30 | $35.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $18.10M derived: sum of 2 quarters · filed 2018-11-09 | $50.70M 10-Q · filed 2018-11-09 | $141.50M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$17.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $15.40M 10-Q · filed 2018-08-09 | $106.20M derived: sum of 3 quarters · filed 2019-03-01 | $142.10M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $32.60M 10-Q · filed 2018-05-10 | $123.40M derived: sum of 2 quarters · filed 2019-03-01 | $159.30M derived: sum of 3 quarters · filed 2019-03-01 | |
| 2016-12-31 | $90.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $126.70M derived: sum of 2 quarters · filed 2019-03-01 | $130.80M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $35.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $40.00M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $4.10M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $229.20M 10-K · filed 2018-03-16 | |||
| 2011-06-30 | $3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | -$25.60M 10-Q · filed 2011-08-09 | ||
| 2011-03-31 | -$29.40M 10-Q · filed 2011-05-09 | |||
| 2010-06-30 | $47.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $53.10M 10-Q · filed 2011-08-09 | ||
| 2010-03-31 | $5.50M 10-Q · filed 2011-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |